Real-Time EEG-Based Epileptic Seizure Prediction Using Artificial Intelligence: A Systematic Review
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Epilepsy affects approximately 50 million people worldwide, and seizures remain difficult to predict in onset, severity, and duration. Real-time seizure prediction may enable proactive intervention and improve patient safety and quality of life. Despite the development of high-performing algorithms, translation remains limited by predictive accuracy, interpretability, and generalisability. Objectives This systematic review evaluates artificial intelligence (AI) models for real-time epileptic seizure prediction and assesses machine learning and deep learning performance alongside real-time responsiveness, interpretability, and multimodal integration. Methods We searched PubMed, Scopus, IEEE Xplore, and ScienceDirect (1 Jan 2017-31 May 2025); 23 studies met eligibility. Inclusion required EEG-based real-time prediction with model/dataset/validation details and sufficient methods for ROBINS-I risk-of-bias assessment. Two reviewers independently screened, extracted, and cross-checked data. False-alarm rate (FAR) was standardised to /h. Results Deep learning consistently outperformed conventional machine learning. CNNs and hybrid CNN-recurrent architectures reported up to 99.01% accuracy, 99.81% sensitivity, and 97.70% specificity. Validation was predominantly patient-specific; three studies adopted patient-independent schemes, and none reported cross-dataset external validation. Reporting of prediction horizon was limited, and latency/energy metrics were rarely provided. Conclusion Despite promising accuracy, the lack of real-world validation and the under-reporting of deployment metrics hinder clinical translation. We recommend standardised evaluation (PS/PI/EXT), an end-to-end latency budget (pre-processing, model runtime, I/O, alert handling), and prospective FAR per 24 h, with prospective and cross-dataset validation to enhance reliability and patient outcomes.